BACKGROUND: Obesity is a risk factor for several cancers in postmenopausal women. We attempted to determine cutoffs of adiposity measures in relation to risk of obesity-related cancers among postmenopausal women and to examine the effects of hormone therapy (HT) use on the cutoffs, neither of which has been broadly studied. METHODS: We used data from the Women's Health Initiative cohort (n=144,701) and applied Cox-proportional hazards regressions to each combination of 17 cancer types and 6 anthropometric measures (weight, body mass index [BMI], weight to height ratio, waist circumference, waist to hip ratio [WHR], and waist to height ratio). Interactions between the anthropometric measures and HT use were also examined. Cutoffs were determined by applying a grid search followed by a two-fold cross validation method. Survival ROC analysis of 5- and 10-year incidence followed. RESULTS: Breast, colorectal, colon, endometrium, kidney, and all cancers combined were significantly positively associated with all six anthropometric measures, whereas lung cancer among ever smokers was significantly inversely associated with all measures except WHR. The derived cutoffs of each obesity measure varied across cancers (e.g., BMI cutoffs for breast and endometrium cancers were 30 kg/m(2) and 34 kg/m(2), respectively), and also depended on HT use. The Youden indices of the cutoffs for predicting 5- and 10-year cancer incidence were higher among HT never users. CONCLUSION: Using a panel of different anthropometric measures, we derived optimal cut-offs categorizing populations into high- and low-risk groups, which differed by cancer type and HT use. Although the discrimination abilities of these risk categories were generally poor, the results of this study could serve as a starting point from which to determine adiposity cutoffs for inclusion in risk prediction models for specific cancer types.
BACKGROUND:Obesity is a risk factor for several cancers in postmenopausal women. We attempted to determine cutoffs of adiposity measures in relation to risk of obesity-related cancers among postmenopausal women and to examine the effects of hormone therapy (HT) use on the cutoffs, neither of which has been broadly studied. METHODS: We used data from the Women's Health Initiative cohort (n=144,701) and applied Cox-proportional hazards regressions to each combination of 17 cancer types and 6 anthropometric measures (weight, body mass index [BMI], weight to height ratio, waist circumference, waist to hip ratio [WHR], and waist to height ratio). Interactions between the anthropometric measures and HT use were also examined. Cutoffs were determined by applying a grid search followed by a two-fold cross validation method. Survival ROC analysis of 5- and 10-year incidence followed. RESULTS: Breast, colorectal, colon, endometrium, kidney, and all cancers combined were significantly positively associated with all six anthropometric measures, whereas lung cancer among ever smokers was significantly inversely associated with all measures except WHR. The derived cutoffs of each obesity measure varied across cancers (e.g., BMI cutoffs for breast and endometrium cancers were 30 kg/m(2) and 34 kg/m(2), respectively), and also depended on HT use. The Youden indices of the cutoffs for predicting 5- and 10-year cancer incidence were higher among HT never users. CONCLUSION: Using a panel of different anthropometric measures, we derived optimal cut-offs categorizing populations into high- and low-risk groups, which differed by cancer type and HT use. Although the discrimination abilities of these risk categories were generally poor, the results of this study could serve as a starting point from which to determine adiposity cutoffs for inclusion in risk prediction models for specific cancer types.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: Geoffrey C Kabat; Moonseong Heo; Jean Wactawski-Wende; Catherine Messina; Cynthia A Thomson; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Cancer Causes Control Date: 2013-04-02 Impact factor: 2.506
Authors: Geoffrey C Kabat; Matthew L Anderson; Moonseong Heo; H Dean Hosgood; Victor Kamensky; Jennifer W Bea; Lifang Hou; Dorothy S Lane; Jean Wactawski-Wende; JoAnn E Manson; Thomas E Rohan Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07-25 Impact factor: 4.254
Authors: Anne McTiernan; Charles Kooperberg; Emily White; Sara Wilcox; Ralph Coates; Lucile L Adams-Campbell; Nancy Woods; Judith Ockene Journal: JAMA Date: 2003-09-10 Impact factor: 56.272
Authors: Elizabeth M Cespedes Feliciano; Ross L Prentice; Aaron K Aragaki; Marian L Neuhouser; Hailey R Banack; Candyce H Kroenke; Gloria Y F Ho; Oleg Zaslavsky; Howard D Strickler; Ting-Yuan David Cheng; Rowan T Chlebowski; Nazmus Saquib; Rami Nassir; Garnet Anderson; Bette J Caan Journal: Int J Cancer Date: 2017-08-31 Impact factor: 7.396
Authors: Oleg Zaslavsky; Eileen Rillamas-Sun; Andrea Z LaCroix; Nancy F Woods; Lesley F Tinker; Anna Zisberg; Efrat Shadmi; Barbara Cochrane; Beatrice J Edward; Stephen Kritchevsky; Marcia L Stefanick; Mara Z Vitolins; Jean Wactawski-Wende; Shira Zelber-Sagi Journal: J Am Geriatr Soc Date: 2016-02 Impact factor: 5.562
Authors: Line Mærsk Staunstrup; Henning Bay Nielsen; Bente Klarlund Pedersen; Morten Karsdal; Joseph Patrick Michele Blair; Jesper Frank Christensen; Cecilie Liv Bager Journal: Sci Rep Date: 2019-03-29 Impact factor: 4.379
Authors: Dorothy A Rhoades; John Farley; Stephen M Schwartz; Kimberly M Malloy; Wenyu Wang; Lyle G Best; Ying Zhang; Tauqeer Ali; Fawn Yeh; Everett R Rhoades; Elisa Lee; Barbara V Howard Journal: Cancer Epidemiol Date: 2021-07-19 Impact factor: 2.890